Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2003-01-28 to 2003-02-25
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2003
Report date:
2003

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Version / remarks:
1996
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Version / remarks:
1996
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
Version / remarks:
June 1996
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Ethyltriphenylphosphonium iodide
EC Number:
225-245-2
EC Name:
Ethyltriphenylphosphonium iodide
Cas Number:
4736-60-1
Molecular formula:
C20H20IP
IUPAC Name:
ethyltriphenylphosphonium iodide

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: approx. 8 weeks
- Weight at study initiation: males 219-357 g, females 164-217 g
- Fasting period before study: Food was withheld overnight (for a maximum of 20 hours) prior to dosing until 3-4 hours after administration of the test substance.
- Housing: 3 animals/sex/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 3
- Humidity (%): 30-70
- Air changes (per hr): app. 15
- Photoperiod (hrs dark / hrs light): 12/12
Deviations from the maximum level for relative humidity (with a maximum of 20%) occurred which might have been caused by cleaning procedures in the room. Based on laboratory historical data these deviations were considered not to have affected the study integrity.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Details on oral exposure:
Vehicle:
- 1% Aqueous carboxymethyl cellulose. The vehicle was selected based on trial formulations performed at study laboratory.

The formulations (w/w) were prepared within 4 hours prior to dosing. Homogeneity was accomplished to a visually acceptable Ievel. The concentration of the test substance in vehicle was varied to allow constant dosage volume in terms of ml/kg body weight.
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw

Doses:
25, 200 and 2000 mg/kg bw
No. of animals per sex per dose:
2000 mg/kg bw: 3 females
200 and 25 mg/kg bw: 3 per sex
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: animals were observed for mortality twice daily. Animals were weighed on Days 1 (pre-administration), 8 and 15 and at death (if found dead after Day 1). Animals were observed for clinical signs at periodic intervals on the day of dosing (Day 1) and once daily thereafter.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, gross necropsy

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 25 - < 200 mg/kg bw
Based on:
test mat.
Mortality:
The incidence of mortality was as follows, presented in chronological order of treatment:
Dose Ievel Mortality Sex
2000 mg/kg 2/3 females
200 mg/kg 1/3 females
200 mg/kg 2/3 males
25 mg/kg 0/3 males
25 mg/kg 0/3 females
Clinical signs:
other: Clinical signs observed during the study period were as follows: Dose Ievel Clinical signs 2000 mg/kg Hunched posture, lethargy, uncoordinated movements, laboured respiration, red staining, chromodacryorrhoea 200 mg/kg
Gross pathology:
At macroscopic post mortem examination small and large intestines distended with gas was found among the animals that died at 2000 mg/kg and red discolouration of the glandular mucosa was found in the male that died at 200 mg/kg. Macroscopic post mortem examination of the other animals that died during the study and of the surviving animals at termination did not reveal any abnormalities.

Applicant's summary and conclusion

Interpretation of results:
Category 2 based on GHS criteria
Conclusions:
Oral LD50 25-200 mg/kg bw; acute oral toxicity category 2 based on the criteria of REGULATION (EC) No 1272/2008 as well as the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations.